Luke Howard

National Heart and Lung Institute, Imperial College London, United Kingdom

Luke Howard is Consultant Chest Physician at Hammersmith Hospital and Honorary Senior Lecturer at the National Heart & Lung Institute, Imperial College, London. He is also on the National Pulmonary Hypertension Service, Department of Cardiac Sciences, Hammersmith Hospital.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Respiratory Disorders > Pulmonary Vascular Diseases (since 20 April 2007)

All recent recommendations

• 3.0
  Changes in exercise hemodynamics during treatment in pulmonary arterial hypertension.
  Recommended by Luke Howard
  
• 4.8
  Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
  Recommended by Luke Howard, Todd Bull
  
• 3.0
  2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug.
  Recommended by Luke Howard